Sherry Morgan-Meadows

Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma

Mace L. Rothenberg, Bonnie LaFleur, Donna E. Levy et al. · Journal of Clinical Oncology · 2005 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors

William R. Schelman, Sherry Morgan-Meadows, Rebecca Marnocha et al. · Cancer Chemotherapy and Pharmacology · 2008 · 34 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase I trial of perillyl alcohol administered four times daily continuously

Sherry Morgan-Meadows, Sarita Dubey, Michael N. Gould et al. · Cancer Chemotherapy and Pharmacology · 2003 · 27 citations

Medicine, Pharmacokinetics, Pharmacology +3

Changes in epidermal growth factor receptor signaling in serum and tumor biopsies obtained from patients with progressive metastatic colorectal cancer (MCRC) treated with gefitinib (ZD1839): an Eastern Cooperative Oncology Group study

Mace L. Rothenberg, Bonnie LaFleur, M. Kay Washington et al. · Journal of Clinical Oncology · 2004 · 21 citations

Medicine, Oncology, Pharmacology +17

A Phase II Trial of Gemcitabine, 5-Fluorouracil and Leucovorin in Advanced Esophageal Carcinoma

Sherry Morgan-Meadows, Daniel Mulkerin, Jordan Berlin et al. · Oncology · 2005 · 14 citations

Medicine, Oncology, Pharmacology +17